{"id":"https://openalex.org/W2053481602","doi":"https://doi.org/10.1021/tx00035a009","title":"Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline","display_name":"Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline","publication_year":1993,"publication_date":"1993-09-01","ids":{"openalex":"https://openalex.org/W2053481602","doi":"https://doi.org/10.1021/tx00035a009","mag":"2053481602","pmid":"https://pubmed.ncbi.nlm.nih.gov/8292742"},"language":"en","primary_location":{"id":"doi:10.1021/tx00035a009","doi":"https://doi.org/10.1021/tx00035a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/tx00035a009","pdf_url":null,"source":{"id":"https://openalex.org/S152840809","display_name":"Chemical Research in Toxicology","issn_l":"0893-228X","issn":["0893-228X","1520-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Research in Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111715294","display_name":"Kent L. Kunze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kent L. Kunze","raw_affiliation_strings":["Department of Medicinal Chemistry, University of Washington, Seattle 98195"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, University of Washington, Seattle 98195","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111461042","display_name":"William F. Trager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William F. Trager","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":7.0922,"has_fulltext":false,"cited_by_count":217,"citation_normalized_percentile":{"value":0.97540323,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"6","issue":"5","first_page":"649","last_page":"656"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/furafylline","display_name":"furafylline","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mechanism-based-inhibition","display_name":"mechanism-based inhibition","score":0.9150000214576721},{"id":"https://openalex.org/keywords/enzyme-inactivation","display_name":"enzyme inactivation","score":0.8820000290870667},{"id":"https://openalex.org/keywords/isoform-selectivity","display_name":"isoform selectivity","score":0.6140000224113464},{"id":"https://openalex.org/keywords/deuterium-isotope-effect","display_name":"deuterium isotope effect","score":0.8399999737739563},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.6959999799728394},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.5529999732971191},{"id":"https://openalex.org/keywords/partition-coefficient","display_name":"partition coefficient","score":0.32899999618530273},{"id":"https://openalex.org/keywords/inactivation-kinetics","display_name":"inactivation kinetics","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8989424705505371},{"id":"https://openalex.org/C86745063","wikidata":"https://www.wikidata.org/wiki/Q3737406","display_name":"CYP1A2","level":4,"score":0.6031911373138428},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.601498007774353},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.5200314521789551},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4010276794433594},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37044578790664673},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.26118001341819763},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25070634484291077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003956","descriptor_name":"Dialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009249","descriptor_name":"NADP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010088","descriptor_name":"Oxidoreductases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019388","descriptor_name":"Cytochrome P-450 CYP1A2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/tx00035a009","doi":"https://doi.org/10.1021/tx00035a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/tx00035a009","pdf_url":null,"source":{"id":"https://openalex.org/S152840809","display_name":"Chemical Research in Toxicology","issn_l":"0893-228X","issn":["0893-228X","1520-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Research in Toxicology","raw_type":"journal-article"},{"id":"pmid:8292742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8292742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical research in toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.46810001134872437,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1895402402","display_name":"ISOTOPE EFFECTS CYTOCHROME P 450 CATALYZED OXIDATIONS","funder_award_id":"R01GM036922","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G3584533173","display_name":null,"funder_award_id":"GM32165","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G3815217008","display_name":null,"funder_award_id":"GM 48750","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G4039931478","display_name":"Drug Interactions","funder_award_id":"P01GM032165","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G4642029356","display_name":"INHIBITION OF HUMAN CYTOCHROME P450 1A2 BY FURAFYLLINE","funder_award_id":"R29GM048750","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G77136015","display_name":null,"funder_award_id":"GM 36922","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1997567581","https://openalex.org/W2014884679","https://openalex.org/W2057893352","https://openalex.org/W1765706822","https://openalex.org/W1746765074","https://openalex.org/W2186076163","https://openalex.org/W1976009884","https://openalex.org/W2101207155","https://openalex.org/W2106909698","https://openalex.org/W7095514085"],"abstract_inverted_index":{"Biotransformation":[0],"reactions":[1],"catalyzed":[2],"by":[3,173,214],"human":[4,48],"cytochrome":[5],"P450":[6,44,86,103,123,143,154,169],"1A2":[7,45,87,124,170],"(P450":[8],"1A2)":[9],"appear":[10],"to":[11,31,153],"play":[12],"a":[13,38,99,117,140,174,179,185,218],"significant":[14],"role":[15,84],"in":[16,47,81,88,148,151,158,210],"both":[17],"the":[18,24,83,94,112,202,215,233],"metabolic":[19,89,193],"clearance":[20],"of":[21,26,43,78,85,102,122,135,142,168,176,181,190,201,206,217,222,238],"drugs":[22,30],"and":[23,29,40,65,119,184,227],"activation":[25],"environmental":[27],"contaminants":[28],"toxic":[32],"or":[33],"carcinogenic":[34],"species.":[35],"Furafylline":[36,115],"is":[37,98,137,147,171,208],"potent":[39],"selective":[41],"inhibitor":[42,101],"activity":[46,125,136,157],"liver":[49],"microsomes":[50,160],"[Sesardic,":[51],"D.,":[52],"Boobis,":[53],"A.,":[54],"Murray,":[55,57],"B.,":[56],"S.,":[58],"Segura,":[59],"J.,":[60],"De":[61],"La":[62],"Torre,":[63],"R.,":[64],"Davies,":[66],"D.":[67],"(1990)":[68],"Br.":[69],"J.":[70],"Clin.":[71],"Pharmacol.":[72],"29,":[73],"651-663]":[74],"which":[75,126,146],"may":[76],"be":[77],"great":[79],"utility":[80],"defining":[82],"processes.":[90],"We":[91],"have":[92],"investigated":[93],"hypothesis":[95,110],"that":[96],"furafylline":[97,186,239],"mechanism-based":[100],"1A2.":[104],"Key":[105],"findings":[106],"consistent":[107],"with":[108,139,242],"this":[109],"are":[111,240],"following:":[113],"(1)":[114],"causes":[116],"time-":[118],"cofactor-dependent":[120],"loss":[121,134],"does":[127],"not":[128],"return":[129],"upon":[130],"dialysis.":[131],"(2)":[132],"The":[133,166,199],"associated":[138],"reduction":[141],"spectral":[144],"content":[145],"turn":[149],"proportional":[150],"amount":[152],"1A2-associated":[155],"catalytic":[156],"uninhibited":[159],"from":[161],"7":[162],"individual":[163],"livers.":[164],"(3)":[165],"inactivation":[167,211],"characterized":[172],"Ki":[175,231],"23":[177],"microM,":[178],"kinact":[180,226],"0.87":[182],"min-1":[183],"depletion-based":[187],"partition":[188],"ratio":[189],"approximately":[191,223],"3-6":[192],"events":[194],"per":[195],"inactivating":[196],"event.":[197],"(4)":[198],"processing":[200],"C-8":[203,234],"methyl":[204,235],"group":[205,236],"furaylline":[207],"involved":[209],"as":[212],"demonstrated":[213],"observation":[216],"deuterium":[219,243],"isotope":[220],"effect":[221,229],"2.0":[224],"on":[225,230],"no":[228],"when":[232],"protons":[237],"replaced":[241],"atoms.(ABSTRACT":[244],"TRUNCATED":[245],"AT":[246],"250":[247],"WORDS)":[248]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}